Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced or Metastatic Hepatocellular Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03422679
What this trial is testing

Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies

Who this might be right for
Breast CancerColorectal CancerAdenoid Cystic Carcinoma+5 more
Cellestia Biotech AG 79
Early research (Phase 1)Active Not RecruitingNCT03257761
What this trial is testing

Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer

Who this might be right for
Extrahepatic Bile Duct Adenocarcinoma, Biliary TypeGallbladder Adenocarcinoma, Biliary TypeMetastatic Pancreatic Adenocarcinoma+25 more
University of Southern California 55
Testing effectiveness (Phase 2)Study completedNCT02089633
What this trial is testing

Pegylated Recombinant Human Arginase 1 in Combination With Oxaliplatin and Capecitabine for the Treatment of HCC

Who this might be right for
Hepatocellular Carcinoma
Bio-Cancer Treatment International Limited 17
Early research (Phase 1)Study completedNCT01183663
What this trial is testing

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 180
Testing effectiveness (Phase 2)Ended earlyNCT04260802
What this trial is testing

Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers

Who this might be right for
CancerNeoplasmsMetastatic Cancer+16 more
Ocellaris Pharma, Inc. 73
Testing effectiveness (Phase 2)Study completedNCT00464919
What this trial is testing

Sorafenib Plus Tegafur/Uracil (UFUR®) for Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
National Taiwan University Hospital 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT04941287
What this trial is testing

Testing A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or Without the Addition of a Third Anti-cancer Drug, Cobimetinib, for Advanced-Stage Biliary Tract Cancer

Who this might be right for
Metastatic Distal Bile Duct AdenocarcinomaMetastatic Gallbladder CarcinomaMetastatic Intrahepatic Cholangiocarcinoma+7 more
National Cancer Institute (NCI) 57
Testing effectiveness (Phase 2)Study completedNCT00604721
What this trial is testing

Selumetinib in Treating Patients With Locally Advanced or Metastatic Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)UnknownNCT00752063
What this trial is testing

Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular CarcinomaMetastatic Hepatocellular Carcinoma
The University of Hong Kong 52
Early research (Phase 1)Study completedNCT00005860
What this trial is testing

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT07174570
What this trial is testing

Celecoxib, Durvalumab and Tremelimumab for the Treatment of Patients With Advanced or Metastatic Liver Cancer

Who this might be right for
Advanced Hepatocellular CarcinomaMetastatic Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v8+1 more
Emory University 39
Testing effectiveness (Phase 2)Looking for participantsNCT06349980
What this trial is testing

Explore the Reasonable Dosage and Evaluate the Efficacy, Safety and Tolerability of HLX10 and HLX04 with or Without HLX53 in Untreated, Locally Advanced or Metastatic Hepatocellular Carcinoma Patients.

Who this might be right for
Carcinoma, Hepatocellular
Shanghai Henlius Biotech 117
Testing effectiveness (Phase 2)Study completedNCT01507168
What this trial is testing

GC33 (RO5137382) in Patients With Advanced or Metastatic Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Hoffmann-La Roche 185
Early research (Phase 1)Looking for participantsNCT06600321
What this trial is testing

Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular CarcinomaMetastatic Hepatocellular Carcinoma
Alnylam Pharmaceuticals 158
Testing effectiveness (Phase 2)Study completedNCT03044587
What this trial is testing

Nal-IRI With 5-fluorouracil (5-FU) and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Biliary-tract Cancer

Who this might be right for
Adenocarcinoma MetastaticBiliary Tract CancerAdenocarcinoma of the Biliary Tract+4 more
AIO-Studien-gGmbH 93
Early research (Phase 1)Ended earlyNCT01219543
What this trial is testing

A Phase I Study of AZD1480 in Patients With Advanced Solid Malignancies and Advanced Hepatocellular Carcinoma in the Escalation Phase,Non-Small Cell Lung Cancer(NSCLC) and Non-smokers With Lung Metastasis and Gastric Cancer and Solid Tumour in the Expansion Phase.

Who this might be right for
Solid TumourAdvanced Solid MalignanciesChild-Pugh A to B7 Advanced Hepatocellular Carcinoma+3 more
AstraZeneca 47
Early research (Phase 1)Study completedNCT00746317
What this trial is testing

A Phase I Study of GC33 in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)

Who this might be right for
Advanced or Metastatic HCC
Chugai Pharmaceutical 27
Testing effectiveness (Phase 2)Looking for participantsNCT05824975
What this trial is testing

Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorSoft Tissue Sarcoma (STS)+6 more
GI Innovation, Inc. 358
Large-scale testing (Phase 3)Active Not RecruitingNCT05904886
What this trial is testing

A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) (IMbrave152)

Who this might be right for
Hepatocellular Carcinoma
Hoffmann-La Roche 687
Early research (Phase 1)Study completedNCT00976170
What this trial is testing

Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)

Who this might be right for
Hepatocellular Carcinoma
Chugai Pharmaceutical 42
Next Page